Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
C3orf56 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CASC10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMIM3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CROCCP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NHS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PREPL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GSG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SMIM20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LPP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AGPAT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRD5A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYCN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPM1H - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIGF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRAME - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB30-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYNN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on